1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immune Cell Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 T Cell Therapy
1.2.3 Natural Killer (NK) Cell Therapy
1.2.4 Other
1.3 Market by Application
1.3.1 Global Immune Cell Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Stomach Cancer
1.3.3 Lung Cancer
1.3.4 Colorectal Cancer
1.3.5 Esophageal Cancer
1.3.6 Pancreatic Cancer
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immune Cell Therapy Market Perspective (2018-2029)
2.2 Immune Cell Therapy Growth Trends by Region
2.2.1 Global Immune Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Immune Cell Therapy Historic Market Size by Region (2018-2023)
2.2.3 Immune Cell Therapy Forecasted Market Size by Region (2024-2029)
2.3 Immune Cell Therapy Market Dynamics
2.3.1 Immune Cell Therapy Industry Trends
2.3.2 Immune Cell Therapy Market Drivers
2.3.3 Immune Cell Therapy Market Challenges
2.3.4 Immune Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immune Cell Therapy Players by Revenue
3.1.1 Global Top Immune Cell Therapy Players by Revenue (2018-2023)
3.1.2 Global Immune Cell Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Immune Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immune Cell Therapy Revenue
3.4 Global Immune Cell Therapy Market Concentration Ratio
3.4.1 Global Immune Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immune Cell Therapy Revenue in 2022
3.5 Immune Cell Therapy Key Players Head office and Area Served
3.6 Key Players Immune Cell Therapy Product Solution and Service
3.7 Date of Enter into Immune Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immune Cell Therapy Breakdown Data by Type
4.1 Global Immune Cell Therapy Historic Market Size by Type (2018-2023)
4.2 Global Immune Cell Therapy Forecasted Market Size by Type (2024-2029)
5 Immune Cell Therapy Breakdown Data by Application
5.1 Global Immune Cell Therapy Historic Market Size by Application (2018-2023)
5.2 Global Immune Cell Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Immune Cell Therapy Market Size (2018-2029)
6.2 North America Immune Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Immune Cell Therapy Market Size by Country (2018-2023)
6.4 North America Immune Cell Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immune Cell Therapy Market Size (2018-2029)
7.2 Europe Immune Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Immune Cell Therapy Market Size by Country (2018-2023)
7.4 Europe Immune Cell Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immune Cell Therapy Market Size (2018-2029)
8.2 Asia-Pacific Immune Cell Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Immune Cell Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Immune Cell Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immune Cell Therapy Market Size (2018-2029)
9.2 Latin America Immune Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Immune Cell Therapy Market Size by Country (2018-2023)
9.4 Latin America Immune Cell Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immune Cell Therapy Market Size (2018-2029)
10.2 Middle East & Africa Immune Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Immune Cell Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Immune Cell Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Adaptimmune
11.1.1 Adaptimmune Company Detail
11.1.2 Adaptimmune Business Overview
11.1.3 Adaptimmune Immune Cell Therapy Introduction
11.1.4 Adaptimmune Revenue in Immune Cell Therapy Business (2018-2023)
11.1.5 Adaptimmune Recent Development
11.2 Altor Bioscience Corporation
11.2.1 Altor Bioscience Corporation Company Detail
11.2.2 Altor Bioscience Corporation Business Overview
11.2.3 Altor Bioscience Corporation Immune Cell Therapy Introduction
11.2.4 Altor Bioscience Corporation Revenue in Immune Cell Therapy Business (2018-2023)
11.2.5 Altor Bioscience Corporation Recent Development
11.3 Cellectis
11.3.1 Cellectis Company Detail
11.3.2 Cellectis Business Overview
11.3.3 Cellectis Immune Cell Therapy Introduction
11.3.4 Cellectis Revenue in Immune Cell Therapy Business (2018-2023)
11.3.5 Cellectis Recent Development
11.4 Juno Therapeutics
11.4.1 Juno Therapeutics Company Detail
11.4.2 Juno Therapeutics Business Overview
11.4.3 Juno Therapeutics Immune Cell Therapy Introduction
11.4.4 Juno Therapeutics Revenue in Immune Cell Therapy Business (2018-2023)
11.4.5 Juno Therapeutics Recent Development
11.5 Kite Pharma
11.5.1 Kite Pharma Company Detail
11.5.2 Kite Pharma Business Overview
11.5.3 Kite Pharma Immune Cell Therapy Introduction
11.5.4 Kite Pharma Revenue in Immune Cell Therapy Business (2018-2023)
11.5.5 Kite Pharma Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Immune Cell Therapy Introduction
11.6.4 Novartis Revenue in Immune Cell Therapy Business (2018-2023)
11.6.5 Novartis Recent Development
11.7 Takara Bio
11.7.1 Takara Bio Company Detail
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio Immune Cell Therapy Introduction
11.7.4 Takara Bio Revenue in Immune Cell Therapy Business (2018-2023)
11.7.5 Takara Bio Recent Development
11.8 Unum Therapeutics
11.8.1 Unum Therapeutics Company Detail
11.8.2 Unum Therapeutics Business Overview
11.8.3 Unum Therapeutics Immune Cell Therapy Introduction
11.8.4 Unum Therapeutics Revenue in Immune Cell Therapy Business (2018-2023)
11.8.5 Unum Therapeutics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
